Abstract:
A connecting terminal for a connector has a fixed portion configured to be connected to an electrode portion provided in a member for mounting the connector, and a contact configured to electrically come in contact with a contact portion of a connected portion to be connected to the connector. At least one concave portion is provided along a whole outer peripheral surface of the connector terminal.
Abstract:
A waste heat recovering and cooling apparatus for an engine includes a water pump that ejects cooling water of an engine; an EGR cooler that cools EGR gas introduced into an intake pipe from an exhaust pipe of the engine by using some of the cooling water ejected from the water pump; an EGR valve that opens and closes the channel of the EGR gas passing through the EGR cooler; and a transmission warmer that heats lubricating oil of a transmission by the cooling water passing through the EGR cooler.
Abstract:
A basic-additional-yaw-moment setting section sets a basic additional yaw moment and determines the polarity of the basic additional yaw moment on the basis of a steering-wheel angle, a yaw rate, and a vehicle speed. A left-right driving-force distribution controller sets the driving-force distribution with respect to left and right driving wheels on the basis of the basic additional yaw moment and the polarity of the basic additional yaw moment, and adjusts the driving-force distribution when a vehicle drive control operation signal is output from a vehicle drive control unit. Specifically, the left-right driving-force distribution control section adjusts the driving-force distribution such that the polarity of the basic additional yaw moment is in the same direction as that of a yaw moment applied by the vehicle drive control unit.
Abstract:
The present invention provides medicines useful for the prevention or treatment of urinary frequency or incontinence. That is, the present invention relates to a medicine comprising combination of a phenoxyacetic acid derivative represented by the following general formula (I) (wherein R1 represents a hydroxy group or a lower alkoxy group) or a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof and an α1 adrenoceptor blocker, which exerts an excellent effect decreasing intra-bladder pressure or prolonging micturition interval and useful for the prevention or treatment of urinary frequency or incontinence.
Abstract:
A differential apparatus having a limited slip differential mechanism which comprises a differential case, a pair of side gears housed in the differential case and connected to driving shafts, and pinion gears meshing with the pair of side gears. One of the tooth surfaces of each tooth of the side gears and the pinion gears has a large pressure angle and the other surface has a small pressure angle, such that meshing reaction forces Dr in a drive mode is larger than that of Co in a coast mode to obtain different limiting forces.
Abstract:
An air flow direction changing device of an air conditioning device according to the present invention includes: a lateral louver which is rotatably provided on the front side of a blowout port of a cabinet; a control section which changes the blowout direction of air sent from a fan by rotatably driving and controlling the lateral louver in the front surface of the blowout port; and a straightening plate which is provided on the rear side of the lateral louver in the blowout port and straighten the air flow from the fan located on the rear side in the passageway, and is configured such that the control section improves the blowing performance by controlling the rotation attitude of the lateral louver in such a manner that, when the lateral louver is held in an upward blowout attitude, an air blowing guide passage longer than the depth length of the lateral louver itself is formed by cooperation of the upper surface of the lateral louver with the upper surface of the straightening plate.
Abstract:
The present invention offers a power steering device for a four-wheel drive, which includes: a first self-aligning torque estimation unit for estimating a self-aligning torque generated in a current vehicle behavior as a first self-aligning torque; a second self-aligning torque estimation unit for estimating a self-aligning torque that is to influence a subsequent vehicle behavior as a second self-aligning torque; a self-aligning torque change amount calculation unit for calculating a difference of the second self-aligning torque from the first self-aligning torque as a self-aligning torque change amount; and an assisting force correction unit for determining and outputting a corrected value of an assisting force to be generated for a steering operation based on the self-aligning torque change amount. Therefore, even when the self-aligning torque changes as the distribution of the front and rear driving power is variably controlled, a corresponding assisting force is generated, maintaining a natural steering feeling without causing an unpleasant sensation to the driver.
Abstract:
A basic-additional-yaw-moment setting section sets a basic additional yaw moment and determines the polarity of the basic additional yaw moment on the basis of a steering-wheel angle, a yaw rate, and a vehicle speed. A left-right driving-force distribution controller sets the driving-force distribution with respect to left and right driving wheels on the basis of the basic additional yaw moment and the polarity of the basic additional yaw moment, and adjusts the driving-force distribution when a vehicle drive control operation signal is output from a vehicle drive control unit. Specifically, the left-right driving-force distribution control section adjusts the driving-force distribution such that the polarity of the basic additional yaw moment is in the same direction as that of a yaw moment applied by the vehicle drive control unit.
Abstract:
The present invention provides pharmaceutical compositions for the prevention or treatment of overactive bladder accompanied with neurogentic disorders. The pharmaceutical compositions comprise as an active ingredient indoline derivatives represented by the following general formula (I) or pharmaceutically acceptable salts thereof and are useful for the prevention or treatment of OAB accompanied with neurogenic disorders such as cerebrovascular disorders, Parkinson's disease, spinal cord involvement or the like. In the formula, R represents an optionally substituted aliphaticacyl group, an optionally substituted lower alkyl group, an optionally substituted aromatic acyl group or the like; R1 represents a cyano group or a carbamoyl group; and R2 represents an optionally substituted lower alkyl group.
Abstract translation:本发明提供了用于预防或治疗伴有神经功能障碍的过度活动性膀胱的药物组合物。 药物组合物包含作为活性成分的由以下通式(I)表示的二氢吲哚衍生物或其药学上可接受的盐,并且可用于预防或治疗伴有神经源性疾病如脑血管障碍,帕金森病,脊髓受累的OAB或 类似。 在该式中,R表示任选取代的脂族酰基,任选取代的低级烷基,任选取代的芳族酰基等; R 1表示氰基或氨基甲酰基; R 2表示任选取代的低级烷基。
Abstract:
There is provided a drive device for a vehicle. A forward clutch that is engaged during forward driving is provided in a power transmission path between an engine and a drive wheel. A spring is incorporated in an engagement oil chamber of the forward clutch, thereby causing the forward clutch to be held in a slipping state or an engaged state through the spring force even during an idling stop that suffers from reduced control oil pressure. This arrangement can prevent the forward clutch from producing an engagement shock during an engine restart. In addition, an input clutch driven by an electric actuator is provided in the power transmission path. With this arrangement, neutral control can be performed by disengaging the input clutch even if the forward clutch which is to be held in a slipping state or an engaged state is provided.